Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Capital Reinvestment Ratio
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Capital Reinvestment Ratio of 0.09x as of September 2024, meaning it reinvests 0% of its operating cash flow (TL33.37 Million) in capital expenditures (TL2.91 Million). See ONCSM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Capital Reinvestment Ratio (2022–2022)
This chart tracks Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2022–2022)
Year-by-year Capital Reinvestment Ratio for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2022 to 2022. For live market cap and broader valuation context, see market cap of Oncosem Onkolojik Sistemler Sanayi ve Ti.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.49x | TL52.69 Million | TL26.02 Million | — |